174 related articles for article (PubMed ID: 23361561)
21. Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer.
Mertz KD; Horcic M; Hailemariam S; D'Antonio A; Dirnhofer S; Hartmann A; Agaimy A; Eppenberger-Castori S; Obermann E; Cathomas G; Bubendorf L
Hum Pathol; 2013 Dec; 44(12):2727-35. PubMed ID: 24074533
[TBL] [Abstract][Full Text] [Related]
22. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
Ciampa A; Xu B; Ayata G; Baiyee D; Wallace J; Wertheimer M; Edmiston K; Khan A
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):132-7. PubMed ID: 16785779
[TBL] [Abstract][Full Text] [Related]
23. TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.
Swanson TA; Krueger SA; Galoforo S; Thibodeau BJ; Martinez AA; Wilson GD; Marples B
Prostate; 2011 Oct; 71(14):1548-58. PubMed ID: 21394739
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical evaluation of ERG expression in various benign and malignant tissues.
Liu H; Shi J; Wilkerson M; Yang XJ; Lin F
Ann Clin Lab Sci; 2013; 43(1):3-9. PubMed ID: 23462600
[TBL] [Abstract][Full Text] [Related]
25. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.
Cornu JN; Cancel-Tassin G; Egrot C; Gaffory C; Haab F; Cussenot O
Prostate; 2013 Feb; 73(3):242-9. PubMed ID: 22821767
[TBL] [Abstract][Full Text] [Related]
26. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
27. Expression of ERG protein in prostate cancer: variability and biological correlates.
Ayala G; Frolov A; Chatterjee D; He D; Hilsenbeck S; Ittmann M
Endocr Relat Cancer; 2015 Jun; 22(3):277-87. PubMed ID: 25972242
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
Dhani NC; Emmenegger U; Adams L; Jongstra J; Tannock IF; Sridhar SS; Knox JJ; Day JR; Groskopf J; Joshua AM
BJU Int; 2012 Sep; 110(6):840-5. PubMed ID: 22313860
[TBL] [Abstract][Full Text] [Related]
29. Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer.
Sabaliauskaite R; Jarmalaite S; Petroska D; Dasevicius D; Laurinavicius A; Jankevicius F; Lazutka JR
Genes Chromosomes Cancer; 2012 Aug; 51(8):781-91. PubMed ID: 22505341
[TBL] [Abstract][Full Text] [Related]
30. Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer.
Jaraj SJ; Camparo P; Boyle H; Germain F; Nilsson B; Petersson F; Egevad L
Virchows Arch; 2009 Oct; 455(4):375-81. PubMed ID: 19760433
[TBL] [Abstract][Full Text] [Related]
31. Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer.
Kron K; Liu L; Trudel D; Pethe V; Trachtenberg J; Fleshner N; Bapat B; van der Kwast T
Clin Cancer Res; 2012 May; 18(10):2896-904. PubMed ID: 22452941
[TBL] [Abstract][Full Text] [Related]
32. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
33. A high-throughput strategy for protein profiling in cell microarrays using automated image analysis.
Strömberg S; Björklund MG; Asplund C; Sköllermo A; Persson A; Wester K; Kampf C; Nilsson P; Andersson AC; Uhlen M; Kononen J; Ponten F; Asplund A
Proteomics; 2007 Jun; 7(13):2142-50. PubMed ID: 17549799
[TBL] [Abstract][Full Text] [Related]
34. Crowdsourcing scoring of immunohistochemistry images: Evaluating Performance of the Crowd and an Automated Computational Method.
Irshad H; Oh EY; Schmolze D; Quintana LM; Collins L; Tamimi RM; Beck AH
Sci Rep; 2017 Feb; 7():43286. PubMed ID: 28230179
[TBL] [Abstract][Full Text] [Related]
35. Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.
Lejeune M; Jaén J; Pons L; López C; Salvadó MT; Bosch R; García M; Escrivà P; Baucells J; Cugat X; Alvaro T
J Anat; 2008 Jun; 212(6):868-78. PubMed ID: 18510512
[TBL] [Abstract][Full Text] [Related]
36. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.
Cerveira N; Ribeiro FR; Peixoto A; Costa V; Henrique R; Jerónimo C; Teixeira MR
Neoplasia; 2006 Oct; 8(10):826-32. PubMed ID: 17032499
[TBL] [Abstract][Full Text] [Related]
37. CXCR4 mRNA overexpression in high grade prostate tumors: lack of association with TMPRSS2-ERG rearrangement.
de Muga S; Hernández S; Salido M; Lorenzo M; Agell L; Juanpere N; Lorente JA; Serrano S; Lloreta J
Cancer Biomark; 2012-2013; 12(1):21-30. PubMed ID: 23321466
[TBL] [Abstract][Full Text] [Related]
38. Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer.
Kolar Z; Burdova A; Jamaspishvili T; Bouchal J; Kucerova R; Bienova M; Kral M; Student V
Neoplasma; 2014; 61(1):9-16. PubMed ID: 24195515
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.
Tsourlakis MC; Schoop M; Plass C; Huland H; Graefen M; Steuber T; Schlomm T; Simon R; Sauter G; Sirma H; Minner S
Hum Pathol; 2013 Sep; 44(9):1789-96. PubMed ID: 23642739
[TBL] [Abstract][Full Text] [Related]
40. Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas.
Nassar A; Cohen C; Albitar M; Agersborg SS; Zhou W; Lynch KA; Heyman ER; Lange H; Siddiqui MT
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):212-7. PubMed ID: 21475038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
